•
Mar 31
Altria Q1 2025 Earnings Report
Altria posted solid results with EPS growth and reaffirmed its full-year guidance.
Key Takeaways
Altria delivered resilient first-quarter results, driven by strong performance in its smokeable products and oral tobacco segments, despite challenges from the e-vapor market and volume declines.
Adjusted EPS rose 6.0% year-over-year to $1.23.
Reported diluted EPS fell 47.9% due to a large non-cash impairment charge.
Smokeable segment adjusted OCI grew 2.7%, driven by higher pricing and cost controls.
Altria reaffirmed its full-year 2025 adjusted EPS growth target of 2% to 5%.
Altria
Altria
Altria Revenue by Segment
Altria Revenue by Geographic Location
Forward Guidance
Altria reaffirmed its 2025 full-year adjusted EPS growth forecast of 2% to 5%, assuming continued investment in smoke-free products and no return of ACE products.
Positive Outlook
- Full-year adjusted EPS growth expected at 2% to 5%.
- Strong cash returns to shareholders via dividends and buybacks.
- Strategic investment in smoke-free alternatives.
- Solid momentum in oral nicotine products (on!).
- Cost savings initiatives expected to drive efficiencies.
Challenges Ahead
- External environment remains dynamic with regulatory risks.
- Potential impacts from illicit e-vapor market growth.
- Tariff-related cost pressures on supply chain.
- Reduced volumes in combustible segments driven by market declines.
- No anticipated reentry of ACE e-vapor product in 2025.
Revenue & Expenses
Visualization of income flow from segment revenue to net income